Role of the agonist binding site in up-regulation of neuronal nicotinic alpha4beta2 receptors.
Long-term exposure to nicotinic ligands results in up-regulation of neuronal nicotinic alpha4beta2 receptors in the brain and in heterologous expression systems. Up-regulation can be produced by a variety of drugs, including nicotinic agonists and competitive antagonists, but previous studies have indicated that the signal for up-regulation does not reflect a traditional nicotinic pharmacology, and the initial steps in signal transduction are not clear. We examined the signal for up-regulation and the possible involvement of the nicotine binding site in signal reception using mutated subunits transiently expressed in human embryonic kidney 293 cells. The data indicate that receptor activation and desensitization are not part of the signaling pathway. However, mutations to residues in the binding site can affect up-regulation. These results provide evidence that the binding site is directly involved in receiving the signal for up-regulation.
Kishi
Masashi
M
Department of Anesthesiology, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis MO 63110, USA.
Steinbach
Joe Henry
JH
D001665:Binding Sites; D002460:Cell Line; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D009154:Mutation; D018722:Nicotinic Agonists / Q000378:metabolism / Q000494:pharmacology*; D011978:Receptors, Nicotinic / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects*
D018722:Nicotinic Agonists; D011978:Receptors, Nicotinic; C403531:nicotinic receptor alpha4beta2